Cipla | CIPLA - Gross Profit On Sales

Stock Price
1,346.00
Daily Change
-12.10 -0.89%
Monthly
1.32%
Yearly
-4.37%
Q1 Forecast
1,315.62

Cipla reported INR41.64B in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Arca Biopharma 0 0 Mar/2025
aTyr Pharma USD 190K 15.57M Sep/2025
Capricor Therapeutics 0 11.13M Mar/2025
Cara Therapeutics USD 2.57M 1.11M Mar/2025
Cipla INR 41.64B 6.31B Dec/2025
Dr.Reddys Laboratories INR 51.37B 629M Dec/2025
Esperion Therapeutics USD -29.52M 32.4M Sep/2024
Immunic 0 0 Mar/2025
Infinity Pharmaceuticals USD 231K 59K Jun/2023
Minerva Neurosciences -4.27M 26.79M Dec/2024
Nektar Therapeutics USD 13.75M 650K Jun/2024
Sangamo BioSciences -2.39M 1.09M Jun/2024
Sun Pharmaceuticals INR 107.66B 2.05B Sep/2025
TherapeuticsMD USD 234K 79K Jun/2024
UPL INR 55.96B 1.01B Dec/2025